3 Reasons Johnson & Johnson Belongs in Your Dividend Portfolio

Finding a great dividend stock is easier said than done. Nevertheless, there are a handful of generous-yielding stocks that could be comfortably added to any income investor's portfolio. One such example is Johnson & Johnson , the pharmaceutical giant behind brands such as Band-Aid, Tylenol, and Neutrogena.

As Motley Fool contributor John Maxfield discusses in the video below, there are three reasons for this. First, Johnson & Johnson has paid uninterrupted dividends for a staggering 52 consecutive years, ranking it among the most consistent dividend payers in the market today. Second, its payout ratio is 50%, which is a comfortable percentage that leaves room for both organic share price appreciation and dividend growth. Finally, with a dividend yield of 2.7%, it handily beats the 1.9% average yield on the S&P 500.

To learn more about why Johnson & Johnson should be considered as an addition to your dividend portfolio, check out the following video.

Looking for high-yielding stocks you can trust?
If so, then I encourage you to check out our latest free list of high-yielding stocks that pay massive dividends without exposing investors to undue risk. To access this valuable list instantly and for free, simply click here now.

The article 3 Reasons Johnson & Johnson Belongs in Your Dividend Portfolio originally appeared on Fool.com.

John Maxfield has no position in any stocks mentioned. The Motley Fool recommends and owns shares of Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2014 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Can't get enough business news?

Sign up for Finance Report by AOL and get everything from retailer news to the latest IPOs delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.